The length of the interleukin-11 receptor stalk determines its capacity for classic signaling
- PMID: 29523682
- PMCID: PMC5925790
- DOI: 10.1074/jbc.RA118.001879
The length of the interleukin-11 receptor stalk determines its capacity for classic signaling
Abstract
Interleukin (IL)-11 is a multifunctional cytokine that was traditionally recognized for its hematopoietic and anti-inflammatory functions, but has recently been shown also to be involved in tumorigenesis. IL-11 signaling is initiated by binding of the cytokine to the IL-11 receptor (IL-11R), which is not directly involved in signaling but required for IL-11 binding to the signal-transducing receptor glycoprotein (gp) 130. In classic signaling, IL-11 binds to the membrane-bound IL-11R to initiate signal transduction. Additionally, IL-11 signaling can be initiated via soluble IL-11R, known as trans-signaling, and this pathway only requires the three extracellular domains of the IL-11R, but not stalk, transmembrane, or intracellular region. Here, we analyzed the role of the IL-11R stalk region, a 55 amino acid stretch connecting the extracellular domains with the transmembrane helix, in classic IL-11 signaling with the help of cytokine-dependent cell lines. We showed that the stalk region is crucial for IL-11 signaling via the membrane-bound IL-11R. Using different deletion variants, we found that a minimal length of 23 amino acid residues is required for efficient signal transduction. We further found that classic IL-11 signaling depended solely on the length, but not the sequence, of the IL-11R stalk region, suggesting that the stalk functions as a spacer in the signaling complex. We previously described the IL-11R stalk region as determinant of proteolysis and regulator of IL-11 trans-signaling. The results presented here reveal an additional function in classic IL-11 signaling, highlighting the importance of the IL-11R stalk in IL-11 signaling.
Keywords: STAT3; cytokine; gp130; interleukin; interleukin-11; interleukin-11 receptor; proliferation; signal transduction; stalk region.
© 2018 Lokau and Garbers.
Conflict of interest statement
The authors declare that they have no conflicts of interest with the contents of this article
Figures







Similar articles
-
Modular organization of Interleukin-6 and Interleukin-11 α-receptors.Biochimie. 2015 Dec;119:175-82. doi: 10.1016/j.biochi.2015.11.005. Epub 2015 Nov 10. Biochimie. 2015. PMID: 26551279
-
Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.J Biol Chem. 2013 May 24;288(21):14756-68. doi: 10.1074/jbc.M113.466169. Epub 2013 Apr 5. J Biol Chem. 2013. PMID: 23564454 Free PMC article.
-
Molecular characterization of the craniosynostosis-associated interleukin-11 receptor variants p.T306_S308dup and p.E364_V368del.FEBS J. 2024 Apr;291(8):1667-1683. doi: 10.1111/febs.17015. Epub 2023 Dec 7. FEBS J. 2024. PMID: 37994264
-
The role of proteolysis in interleukin-11 signaling.Biochim Biophys Acta Mol Cell Res. 2022 Jan;1869(1):119135. doi: 10.1016/j.bbamcr.2021.119135. Epub 2021 Oct 6. Biochim Biophys Acta Mol Cell Res. 2022. PMID: 34624437 Review.
-
Proteolytic control of Interleukin-11 and Interleukin-6 biology.Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt B):2105-2117. doi: 10.1016/j.bbamcr.2017.06.008. Epub 2017 Jun 16. Biochim Biophys Acta Mol Cell Res. 2017. PMID: 28630024 Review.
Cited by
-
Interleukin-11 (IL-11) receptor cleavage by the rhomboid protease RHBDL2 induces IL-11 trans-signaling.FASEB J. 2021 Mar;35(3):e21380. doi: 10.1096/fj.202002087R. FASEB J. 2021. PMID: 33566379 Free PMC article.
-
Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11.Front Immunol. 2020 Jul 16;11:1424. doi: 10.3389/fimmu.2020.01424. eCollection 2020. Front Immunol. 2020. PMID: 32765502 Free PMC article. Review.
-
Roles of IL-11 in the regulation of bone metabolism.Front Endocrinol (Lausanne). 2024 Jan 30;14:1290130. doi: 10.3389/fendo.2023.1290130. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38352248 Free PMC article. Review.
-
Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy.J Exp Clin Cancer Res. 2019 Feb 8;38(1):63. doi: 10.1186/s13046-019-1072-8. J Exp Clin Cancer Res. 2019. PMID: 30736824 Free PMC article.
-
The interleukin-11 receptor variant p.W307R results in craniosynostosis in humans.Sci Rep. 2023 Aug 18;13(1):13479. doi: 10.1038/s41598-023-39466-y. Sci Rep. 2023. PMID: 37596289 Free PMC article.
References
-
- Paul S. R., Bennett F., Calvetti J. A., Kelleher K., Wood C. R., O'Hara R. M. Jr., Leary A. C., Sibley B., Clark S. C., and Williams D. A. (1990) Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl. Acad. Sci. U.S.A. 87, 7512–7516 10.1073/pnas.87.19.7512 - DOI - PMC - PubMed
-
- Orazi A., Cooper R. J., Tong J., Gordon M. S., Battiato L., Sledge G. W. Jr., Kaye J. A., Kahsai M., and Hoffman R. (1996) Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow. Exp. Hematol. 24, 1289–1297 - PubMed
-
- Trepicchio W. L., Wang L., Bozza M., and Dorner A. J. (1997) IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB. J. Immunol. 159, 5661–5670 - PubMed
-
- Ernst M., Najdovska M., Grail D., Lundgren-May T., Buchert M., Tye H., Matthews V. B., Armes J., Bhathal P. S., Hughes N. R., Marcusson E. G., Karras J. G., Na S., Sedgwick J. D., Hertzog P. J., and Jenkins B. J. (2008) STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J. Clin. Invest. 118, 1727–1738 10.1172/JCI34944 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous